Dietary acid load and rapid progression to end-stage renal disease of diabetic nephropathy in westernized South Asian people

Journal of Nephrology

Volumn 24, Issue 1, 2011, Pages 11-17

  Van Den Berg, Else ^a,b   Hospers, Frédérique A P ^b   Navis, Gerjan ^a,b   Engberink, Marielle F ^a,c   Brink, Elizabeth J ^a,d   Geleijnse, Johanna M ^a,c   Van Baak, Marleen A ^a,e   Gans, Rijk O B ^b   Bakker, Stephan J L ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d TNO   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Ammonia; Diabetic nephropathy; End stage renal disease; Metabolic acidosis; Proteinuria

Indexed keywords

BICARBONATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE;

ACID BASE BALANCE; ACIDIFICATION; ACIDITY; ALKALINIZATION; AMMONIA FORMATION; ASIAN; CAUCASIAN; CULTURAL FACTOR; DIABETIC NEPHROPATHY; DIETARY INTAKE; DISEASE COURSE; DRUG EFFICACY; EATING HABIT; EPIDEMIC; ETHNIC DIFFERENCE; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; IMMIGRANT; INCIDENCE; KIDNEY FAILURE; KIDNEY INJURY; METABOLIC ACIDOSIS; NONHUMAN; OBESITY; REVIEW; RISK FACTOR; SUPPLEMENTATION; URINARY EXCRETION;

ACCULTURATION; ACID-BASE EQUILIBRIUM; ACIDOSIS; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETIC NEPHROPATHIES; DIET; DISEASE PROGRESSION; EMIGRATION AND IMMIGRATION; FOOD HABITS; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE, CHRONIC; RISK ASSESSMENT; RISK FACTORS; WESTERN WORLD;

EID: 78651108768     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2010.5711     Document Type: Review

References (69)

1. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34:795-808.
2. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-860.
3. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341:1127-1133.
4. Gross ML, Dikow R, Ritz E. Diabetic nephropathy: recent insights into the pathophysiology and the progression of diabetic nephropathy. Kidney Int Suppl. 2005;(94):S50-S53.
5. Burden AC, McNally PG, Feehally J, Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med. 1992;9:641-645.
6. Feehally J, Burden AC, Mayberry JF, et al. Disease variations in Asians in Leicester. Q J Med. 1993;86:263-269.
7. Chandie Shaw PK, Vandenbroucke JP, Tjandra YI, et al. Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia. 2002;45:337-341.
8. Chandie Shaw PK, Baboe F, van Es LA, et al. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care. 2006;29:1383-1385.
9. Lightstone L, Rees AJ, Tomson C, et al. High incidence of end-stage renal disease in Indo-Asians in the UK. QJM. 1995;88:191-195.
10. Roderick PJ, Jones I, Raleigh VS, McGeown M, Mallick N. Population need for renal replacement therapy in Thames regions: ethnic dimension. BMJ. 1994;309:1111-1114.
11. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J. Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes. 2004;53:2449-2454.
12. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940-945.
13. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1995;25:710-713.
14. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21:387-393.
15. Butkus DE. Familial clustering of end-stage renal disease in Mississippi. J Miss State Med Assoc. 2002;43:71-77.
16. Goldfarb-Rumyantzev AS, Cheung AK, Habib AN, et al. A population-based assessment of the familial component of chronic kidney disease mortality. Am J Nephrol. 2006;26:142-148.
17. Hodgkinson AD, Millward BA, Demaine AG. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care. 2003;26:3111-3115.
18. Matsunaga-Irie S, Maruyama T, Yamamoto Y, et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care. 2004;27:303-307.
19. Janssen B, Hohenadel D, Brinkkoetter P, et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes. 2005;54:2320-2327.
20. Lim SC, Goh SK, Lai YR, et al. Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of Type 2 diabetes in a Chinese population. Diabet Med. 2006;23:1037-1041.
21. Osterholm AM, He B, Pitkaniemi J, et al. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int. 2007;71:140-145.
22. Cutting TM, Fisher JO, Grimm-Thomas K, Birch LL. Like mother, like daughter: familial patterns of overweight are mediated by mothers' dietary disinhibition. Am J Clin Nutr. 1999;69:608-613.
23. Toubro S, Sorensen TI, Hindsberger C, Christensen NJ, Astrup A. Twenty-four-hour respiratory quotient: the role of diet and familial resemblance. J Clin Endocrinol Metab. 1998;83:2758-2764.
24. Tai ES, Tan CE. Genes, diet and serum lipid concentrations: lessons from ethnically diverse populations and their relevance to coronary heart disease in Asia. Curr Opin Lipidol. 2004;15:5-12.
25. Jones CA, Krolewski AS, Rogus J, et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int. 2005;67:1684-1691.
26. McDonald JT, Kennedy S. Insights into the 'healthy immigrant effect': health status and health service use of immigrants to Canada. Soc Sci Med. 2004;59:1613-1627.
27. Anderson AS, Bush H, Lean M, et al. Evolution of atherogenic diets in South Asian and Italian women after migration to a higher risk region. J Hum Nutr Diet. 2005;18:33-43.
28. Singh GK, Siahpush M. Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol. 2002;74:83-109.
29. Koya DL, Egede LE. Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med. 2007;22:841-846.
30. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95:I14-I21.
31. Neuhouser ML, Thompson B, Coronado GD, Solomon CC. Higher fat intake and lower fruit and vegetables intakes are associated with greater acculturation among Mexicans living in Washington State. J Am Diet Assoc. 2004;104:51-57.
32. Lv N, Cason KL. Dietary pattern change and acculturation of Chinese Americans in Pennsylvania. J Am Diet Assoc. 2004;104:771-778.
33. Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes. 2002;51:1655-1662.
34. Sebastian A, Frassetto LA, Sellmeyer DE, Merriam RL, Morris RC Jr. Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. Am J Clin Nutr. 2002;76:1308-1316.
35. Sherman HC, Gettler AO. The balance of acid-forming and base-forming elements in foods, and its relation to ammonia metabolism. J Biol Chem. 1912;11:323-338.
36. Gonick HC, Goldberg G, Mulcare D. Reexamination of the acid-ash content of several diets. Am J Clin Nutr. 1968;21:898-903.
37. Frassetto L, Morris RC Jr, Sellmeyer DE, Todd K, Sebastian A. Diet, evolution and aging: the pathophysiologic effects of the post-agricultural inversion of the potassium-to-sodium and base-to-chloride ratios in the human diet. Eur J Nutr. 2001;40:200-213.
38. Varghese S, Moore-Orr R. Dietary acculturation and health-related issues of Indian immigrant families in Newfoundland. Can J Diet Pract Res. 2002;63:72-79.
39. Hallan SI, Stevens P. Screening for chronic kidney disease: which strategy? J Nephrol. 2010;23:147-155.
40. Garcia-Garcia G, Marquez-Magana I, Renoirte-Lopez K, et al. Screening for kidney disease on World Kidney Day in Jalisco, Mexico. J Nephrol. 2010;23:224-230.
41. Atkins RC, Zimmet P. Diabetic kidney disease: act now or pay later. J Nephrol. 2010;23:1-4.
42. Vernaglione L. The Mediterranean diet: a matter of history, tradition, culture and health. J Nephrol. 2009;22(Suppl 14):149-158.
43. Francini-Pesenti F, Calo LA, Fiore C, et al. Diet and the kidney. J Nephrol. 2009;22(Suppl 14):139-142.
44. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95:791-797.
45. Frassetto LA, Morris RC Jr, Sebastian A. A practical approach to the balance between acid production and renal acid excretion in humans. J Nephrol. 2006;19(Suppl 9):S33-S40.
46. Remer T. Influence of nutrition on acid-base balance: metabolic aspects. Eur J Nutr. 2001;40:214-220.
47. Tanner GA. Renal regulation of acid-base balance: ammonia excretion. Physiologist. 1984;27:95-97.
48. Smogorzewski MJ. Historical perspective on the role of the kidney in acid-base regulation. J Nephrol. 2009;22(Suppl 14):108-114.
49. Nath KA, Hostetter MK, Hostetter TH. Increased ammonia-genesis as a determinant of progressive renal injury. Am J Kidney Dis. 1991;17:654-657.
50. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats: interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest. 1985;76:667-675.
51. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627-1637.
52. Morcos M, Sayed AA, Bierhaus A, et al. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes. 2002;51:3532-3544.
53. Peake PW, Pussell BA, Mackinnon B, Charlesworth JA. The effect of pH and nucleophiles on complement activation by human proximal tubular epithelial cells. Nephrol Dial Transplant. 2002;17:745-752.
54. Morita Y, Ikeguchi H, Nakamura J, et al. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol. 2000;11:700-707.
55. Bakris GL, Gaber AO, Jones JD. Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. Radiology. 1990;175:57-60.
56. Atkins JL. Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron. 1986;44:70-74.
57. Katholi RE, Woods WT Jr, Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32:64-71.
58. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328-2334.
59. Recio-Mayoral A, Chaparro M, Prado B, et al. The renoprotective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol. 2007;49:1283-1288.
60. Ozcan EE, Guneri S, Akdeniz B, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy: a comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures: a single-center prospective controlled trial. Am Heart J. 2007;154:539-544.
61. Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:617-627.
62. Rashidi A, Nakhjavani M, Esteghamati A, et al. Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients. J Nephrol. 2009;22:733-738.
63. Baroni EA, Costa RS, Volpini R, Coimbra TM. Sodium bicarbonate treatment reduces renal injury, renal production of transforming growth factor-beta, and urinary transforming growth factor-beta excretion in rats with doxorubicin-induced nephropathy. Am J Kidney Dis. 1999;34:328-337.
64. Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int. 2008;73:192-199.
65. Coffman TM, Crowley SD. Kidney in hypertension: guyton redux. Hypertension. 2008;51:811-816.
66. Luno J, Rodriguez-Iturbe B, Ayus JC. Hypertension and cardiovascular risk in chronic kidney disease patients. J Am Soc Nephrol. 2006;17:S157-S158.
67. Zhang L, Curhan GC, Forman JP. Diet-dependent net acid load and risk of incident hypertension in United States women. Hypertension. 2009;54:751-755.
68. Cirillo M, Del Giudice L, Bilancio G, Franzese MD, De Santo NG. Low salt diet and treatment of hypertension: an old story. J Nephrol. 2009;22(Suppl 14):136-138.
69. Titze J, Ritz E. Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle. J Nephrol. 2009;22:177-189.